HB 1297 revises Florida’s electronic prescribing law to expand the group of health care practitioners who are required to transmit prescriptions electronically for certain medicinal drugs when they maintain, or practice within, a health care setting that maintains, an electronic health records system. The bill updates section 456.42, Florida Statutes, and retains a number of exceptions to the e-prescribing mandate, including situations involving emergencies, technical failures, FDA-required non-electronic elements, hospice or nursing home patients, research protocols, and patient-specific circumstances where electronic prescribing would be impractical or not in the patient’s best interest. It also allows for waivers based on hardship or technological limitations and clarifies that pharmacists may still fill valid written or electronic prescriptions.
In addition to the e-prescribing changes, the bill makes conforming amendments to the physician assistant statutes in chapters 458 and 459. Those changes update cross-references so that physician assistants’ prescribing and dispensing authority remains aligned with the revised electronic prescribing requirements and related recordkeeping rules. The bill takes effect July 1, 2025.
The bill would amend Florida’s prescription and physician assistant statutes by tightening and clarifying when prescriptions must be sent electronically, while preserving multiple statutory exceptions and waiver pathways. It would affect licensed prescribers who use electronic health records, pharmacies that fill prescriptions, and physician assistants operating under delegated prescriptive authority, but it does not eliminate paper prescriptions in all circumstances. The conforming amendments in ss. 458.347 and 459.022 ensure that physician assistant prescribing provisions continue to reference the updated e-prescribing requirements.
The available legislative record shows little direct debate or recorded vote detail, but the bill’s progression indicates it was considered a routine regulatory update rather than a highly controversial measure. The fact that it ultimately died in Senate Rules suggests it did not complete the legislative process, though the context provided does not show whether that was due to opposition, time constraints, or broader procedural issues. Overall, the bill appears to have been framed as a technical and administrative modernization of prescribing rules.
The main points of potential contention are the scope of the electronic prescribing mandate and the breadth of the exceptions. Practitioners may view the requirement as burdensome where technology, cost, or workflow limitations make compliance difficult, while supporters would likely emphasize efficiency, safety, and standardization. The bill’s patient-centered exceptions—especially those allowing paper prescriptions when electronic transmission would be impractical, when price comparison is desired, or when a waiver is justified—suggest an attempt to balance access concerns against the push for broader e-prescribing.